Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by unNoteableon Dec 17, 2021 9:56am
228 Views
Post# 34240216

RE:RE:RE:RE:RE:RE:RE:Curious about Monday at ASH, nothing noted about this

RE:RE:RE:RE:RE:RE:RE:Curious about Monday at ASH, nothing noted about this Canadafan - ONCY is worth whatever the market prices it as... After 20+ years they still do not have in vivo data credible enough to entice big pharma to invest in a Phase III.

When this was $3, you were saying how this company was going to the moon, and how much it was undervalued.

If anyone had taken your advice and bought in for fear of missing out, they would be on more than a 50% loss... I have yet to see one of your price predictions come true... you sir, should be ashamed for pumping this ^&* and creating a FOMO environment for would be investors.

Stay away folks UNTIL this company has real meaningful data to show, you may miss the bottom, but at least you won't lose half your investment.
<< Previous
Bullboard Posts
Next >>